All articles tagged with #stanford medicine
A Stanford Medicine study published in Science shows that blocking the aging protein 15-PGDH can regenerate knee cartilage in mice and human tissue, potentially offering a non-surgical alternative to joint replacement for osteoarthritis.
Stanford researchers discovered that blocking the aging protein 15-PGDH can restore cartilage in mice and human tissue. This approach reverses age-related joint damage and prevents arthritis after injury, potentially replacing joint surgeries with a simple drug.
Researchers at Stanford Medicine and the VA Palo Alto Health Care System developed uRARE-seq, a urine-based liquid biopsy that detects localized bladder cancer with 95% sensitivity and 90% specificity. Unlike DNA-based tests, this method analyzes cell-free RNA to assess tumor activity, distinguishing between low- and high-grade cancers. The test also predicts whether patients will respond to BCG immunotherapy or require chemotherapy, potentially reducing the need for invasive cystoscopies and optimizing treatment allocation.
A new study led by Stanford Medicine reveals that the human brain develops from two separate progenitor cell lines rather than one. This dual-origin model explains why hindbrain neurons are difficult to grow in labs and offers new avenues for treating diseases like ALS and SMA.
A study published in Nature Neuroscience on September 18, 2026, challenges the traditional view that the human brain develops from a single progenitor cell. Researchers from Stanford Medicine found that the forebrain/midbrain and hindbrain arise from two separate, parallel neural ectoderm populations during embryonic gastrulation. This finding explains why hindbrain neurons have been difficult to cultivate in labs and enables the first successful derivation of hindbrain motor neurons from human pluripotent stem cells, offering new avenues for studying diseases like ALS and SMA.
A new study led by Stanford Medicine researchers, published in Nature Neuroscience on September 18, 2026, challenges the long-held belief that the human brain develops from a single progenitor cell. Instead, the research indicates the brain consists of two distinct organs—the forebrain and hindbrain—that arise from separate, parallel developmental pathways during embryonic gastrulation. This discovery explains why scientists previously failed to grow hindbrain neurons in labs and opens new avenues for studying neurodegenerative diseases like ALS and spinal muscular atrophy (SMA). The findings suggest this dual-origin structure is evolutionarily conserved, tracing back at least 550 million years to ancestors like acorn worms.
A Stanford-led study published in Nature Neuroscience on September 18, 2026, demonstrates that the human brain originates from two distinct progenitor cell lines rather than a single unified source. Researchers found that the forebrain and hindbrain develop independently during embryonic gastrulation, a finding that explains why hindbrain neurons have been difficult to cultivate in labs. This discovery enables the first successful generation of human hindbrain motor neurons, offering new avenues for studying spinal muscular atrophy and ALS.
Stanford Medicine researchers have developed a nasal spray vaccine that activates the lungs’ innate immune system to provide months-long protection against a broad range of respiratory threats—including SARS-CoV-2, other coronaviruses, bacterial pneumonia pathogens, and even house dust mite allergens—in mice. If safety and efficacy are shown in humans, the approach could reduce the need for multiple yearly vaccines and idea of rapid protection during outbreaks, with Phase I trials moving forward and an estimated 5–7 years before potential availability.
A Stanford Medicine study indicates that mRNA COVID-19 vaccines can cause myocarditis, especially in young men and adolescents, with a very low incidence rate, but most cases recover fully and the benefits of vaccination outweigh the risks.
A Stanford Medicine clinical trial has shown promising results using CAR-T cell therapy to treat diffuse intrinsic pontine glioma (DIPG), a typically incurable childhood brain cancer. Of 11 participants, nine showed benefits, with one experiencing a complete tumor disappearance. The trial, which received a regenerative medicine advanced therapy designation from the FDA, marks a significant step forward in treating solid tumors with engineered immune cells. Researchers aim to refine the therapy to enhance its effectiveness and reduce side effects.
Stanford Medicine research reveals that adaptive myelination, a process crucial for learning and skill acquisition, can also promote opioid addiction by enhancing the brain's reward circuitry. In mice, a single dose of morphine triggered myelination of dopamine-producing neurons, leading to drug-seeking behavior. Blocking myelination prevented addiction, suggesting potential strategies for treating opioid dependence.
Stanford Medicine researchers have developed a new artificial intelligence model that can distinguish between male and female brains with over 90% accuracy, revealing distinct brain organization patterns. The study, published in the Proceedings of the National Academy of Sciences, suggests that understanding these differences is crucial for addressing neuropsychiatric conditions affecting women and men differently. The model identified key brain networks contributing to the differences and successfully predicted cognitive performance based on sex-specific brain features. The research was sponsored by the National Institutes of Health and aims to make the model publicly available for broader applications.
A new study using an artificial intelligence model has shown that there are distinct differences in brain activity between men and women, particularly in areas such as the default mode network, striatum, and limbic network. These findings support the idea that biological sex shapes the brain and may help shed light on brain conditions that affect men and women differently. The AI model was able to distinguish between male and female brain scans with over 90% accuracy, and the study's "explainable" nature allowed researchers to identify which brain regions were most important in determining a person's sex.
A new study conducted by researchers at Stanford Medicine has found compelling evidence that a vegan diet can significantly improve heart health in just two months. The study involved 22 pairs of identical twins, with one twin following a vegan diet and the other an omnivorous diet. After eight weeks, the vegan group showed lower LDL cholesterol, insulin, and body weight compared to the omnivorous group. The results suggest that a healthy plant-based diet offers a protective advantage for cardiometabolic health. This randomized controlled trial provides strong evidence supporting the health benefits of a vegan diet, which has been linked to lower rates of Type 2 diabetes, heart disease, and obesity in previous observational studies.
A clinical trial conducted by Stanford Medicine using deep-brain stimulation has shown promising results in restoring cognitive functions and improving daily life activities for individuals with moderate to severe brain injuries. The technique, tailored to each patient, exceeded expectations and is the first to offer hope for long-lasting impairments caused by traumatic brain injuries. The trial involved five participants who experienced significant improvements in cognitive abilities after the implantation of a device that stimulated specific brain networks. The success of the trial highlights a breakthrough in brain injury treatment and paves the way for further advancements in this field.